FAQ: Forian Inc. Unsolicited Proposal to Go Private
Summary
Forian Inc. has received an unsolicited proposal from CEO Max Wygod and other insiders to take the company private at $2.10 per share. The Board has formed a Special Committee to evaluate this non-binding proposal, which is contingent on financing and other conditions.
What is the main announcement in this press release?
Forian Inc. has received an unsolicited, preliminary, non-binding proposal from CEO Max Wygod and other insiders to take the company private at $2.10 per share to other shareholders.
Who is leading the proposal to take Forian private?
The proposal is led by Max Wygod, Forian’s founder, Executive Chairman and Chief Executive Officer, along with inside directors Adam Dublin and Shahir Kassam-Adams, who collectively own approximately 63% of the company’s common stock.
What is the proposed purchase price per share?
The proposal offers $2.10 per share to Forian’s other shareholders (excluding the proposing group who already own approximately 63% of the stock).
How is the company responding to this proposal?
The Board of Directors has established a Special Committee consisting of independent directors who will evaluate the proposal with their advisors and determine the appropriate course of action and process.
What are the main conditions for this proposal to proceed?
The proposal is conditioned on receiving financing for the transaction, negotiating satisfactory employment agreements and a definitive acquisition agreement, approval by the Special Committee, and acquiring a majority of the company’s common stock.
Is this proposal guaranteed to result in a transaction?
No, there is no assurance that any definitive offer will be received, that any acquisition agreement will be executed, or that this or any other transaction will be approved or consummated.
What does Forian Inc. do as a company?
Forian provides data management capabilities and proprietary information and analytics solutions to optimize operational, clinical and financial performance for customers in life sciences, healthcare, and financial services industries.
When was this proposal made?
The proposal letter is dated August 25, 2025, and the press release was issued on the same date.
What should shareholders expect regarding updates on this proposal?
The company does not undertake any obligation to provide updates except as required under applicable law, meaning shareholders should monitor official company communications and regulatory filings for any developments.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at NewMediaWire
Article Control ID: 179489